| Primary |
| Product Used For Unknown Indication |
39.1% |
| Medical Observation |
10.6% |
| Tinea Pedis |
10.6% |
| Tinea Cruris |
9.3% |
| Rash |
6.8% |
| Pruritus |
4.3% |
| Tinea Infection |
3.7% |
| Fungal Infection |
1.9% |
| Atrial Fibrillation |
1.2% |
| Burning Sensation |
1.2% |
| Diabetes Mellitus |
1.2% |
| Discomfort |
1.2% |
| Erythema |
1.2% |
| Hypertension |
1.2% |
| Oedema Peripheral |
1.2% |
| Onychomycosis |
1.2% |
| Pain |
1.2% |
| Skin Fissures |
1.2% |
| Blood Cholesterol Increased |
0.6% |
| Candidiasis |
0.6% |
|
| Drug Ineffective |
39.2% |
| Off Label Use |
13.4% |
| Drug Effect Decreased |
12.4% |
| Condition Aggravated |
5.2% |
| Skin Irritation |
4.1% |
| Rash |
3.1% |
| Skin Exfoliation |
3.1% |
| Urticaria |
3.1% |
| Application Site Pain |
2.1% |
| Incorrect Drug Administration Duration |
2.1% |
| Pruritus |
2.1% |
| Renal Pain |
2.1% |
| Application Site Erythema |
1.0% |
| Blister |
1.0% |
| Drug Administered At Inappropriate Site |
1.0% |
| Dry Mouth |
1.0% |
| Dry Skin |
1.0% |
| Erythema |
1.0% |
| Expired Drug Administered |
1.0% |
| Feeling Abnormal |
1.0% |
|
| Secondary |
| Medical Observation |
24.5% |
| Rash |
8.5% |
| Onychomycosis |
7.5% |
| Product Used For Unknown Indication |
6.6% |
| Tinea Cruris |
6.6% |
| Tinea Pedis |
6.6% |
| Pruritus |
5.7% |
| Atrial Fibrillation |
3.8% |
| Diabetes Mellitus |
3.8% |
| Oedema Peripheral |
3.8% |
| Tinea Infection |
3.8% |
| Erythema |
2.8% |
| Fungal Infection |
2.8% |
| Blood Cholesterol Increased |
1.9% |
| Burning Sensation |
1.9% |
| Candidiasis |
1.9% |
| Discomfort |
1.9% |
| Hypothyroidism |
1.9% |
| Pain |
1.9% |
| Skin Fissures |
1.9% |
|
| Off Label Use |
24.3% |
| Drug Ineffective |
21.6% |
| Drug Effect Decreased |
16.2% |
| Skin Irritation |
5.4% |
| Urticaria |
5.4% |
| Wrong Technique In Drug Usage Process |
5.4% |
| Condition Aggravated |
2.7% |
| Dry Mouth |
2.7% |
| Erythema |
2.7% |
| Expired Drug Administered |
2.7% |
| Incorrect Drug Administration Duration |
2.7% |
| Peripheral Coldness |
2.7% |
| Skin Exfoliation |
2.7% |
| Therapeutic Response Unexpected |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
62.1% |
| Pain |
6.9% |
| Blood Cholesterol Increased |
3.4% |
| Fungal Skin Infection |
3.4% |
| Growth Hormone Deficiency |
3.4% |
| Hypertension |
3.4% |
| Oedema Peripheral |
3.4% |
| Prostate Cancer |
3.4% |
| Prostate Cancer Metastatic |
3.4% |
| Smoking Cessation Therapy |
3.4% |
| Tinea Cruris |
3.4% |
|
| Rocky Mountain Spotted Fever |
25.0% |
| Skin Disorder |
25.0% |
| Thinking Abnormal |
25.0% |
| Unevaluable Event |
25.0% |
|
